Author:
Harbeck Nadia,Würstlein Rachel,Burgmann Maximiliane
Publisher
Springer Berlin Heidelberg
Reference73 articles.
1. Aapro M (2011) SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly. Hematol Rep 3(3s), e6. doi:
10.4081/hr.2011.s3.e6
2. AGO-Kommission „Mamma“ (2017) Empfehlungen 2017 für die Behandlung des primären und des metastasierten Mammakarzinoms:
https://www.ago-online.de/de/infothek-fuer-aerzte/kommissionen/kommission-mamma/
. Zugegriffen am 15.06.2017
3. Aprile G, Ferrari L, Fontanella C, Puglisi F (2013) Bevacizumab in older patients with advanced colorectal or breast cancer. Crit Rev Oncol Hematol 87(1):41–54. doi:
10.1016/j.critrevonc.2012.11.006
4. Bachelot T, Pérez-Alcántara F, Ciruelos E, Peretz-Yablonski T, Schneeweiss A, Easton V, Lindegger N, Restuccia E, Miles D (2016) Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent/metastatic breast cancer (PERUSE). SABCS 2016, P4-21-04
5. Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Breast Cancer Groups et al (2015) Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol 16(1):47–56. doi:
10.1016/S1470-2045(14)71156-8